Trial Reporting in Immuno-Oncology (TRIO): an American society of clinical oncology-society for immunotherapy of cancer statement

PURPOSE: To develop recommendations for clinical trial reporting that address the unique efficacy, toxicity, and combination and sequencing aspects of immuno-oncology (IO) treatments. METHODS: ASCO and the Society for Immunotherapy of Cancer (SITC) convened a working group that consisted of practici...

Descripción completa

Detalles Bibliográficos
Autores principales: Tsimberidou, Apostolia M., Levit, Laura A., Schilsky, Richard L., Averbuch, Steven D., Chen, Daniel, Kirkwood, John M., McShane, Lisa M., Sharon, Elad, Mileham, Kathryn F., Postow, Michael A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Position Article and Guidelines
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6195705/
https://www.ncbi.nlm.nih.gov/pubmed/30340549
http://dx.doi.org/10.1186/s40425-018-0426-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6195705/
https://www.ncbi.nlm.nih.gov/pubmed/30340549
http://dx.doi.org/10.1186/s40425-018-0426-7

Ejemplares similares